Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Mereo BioPharma Group plc - American Depositary Shares (NQ:MREO)

0.2761 +0.0061 (+2.26%)
Streaming Delayed Price Updated: 2:38 PM EDT, Sep 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,082,091
Open 0.2700
Bid (Size) 0.2754 (200)
Ask (Size) 0.2767 (7,300)
Prev. Close 0.2700
Today's Range 0.2700 - 0.2878
52wk Range 0.2000 - 2.370
Shares Outstanding 584,908,239
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Which stocks are most active on Tuesday? ↗
Via Chartmill
Here are the top movers in Tuesday's session. ↗
Via Chartmill

Performance

YTD
-45.9%
-45.9%
1 Month
-12.5%
-12.5%
3 Month
-10.3%
-10.3%
6 Month
-30.5%
-30.5%
1 Year
-84.4%
-84.4%

More News

Read More
These stocks that are showing activity before the opening bell on Tuesday. ↗
Via Chartmill
News headline image
Mereo BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Highlights
From Mereo BioPharma Group plc
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Via Benzinga
News headline image
Mereo BioPharma and Sentynl Therapeutics Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD)
From Mereo BioPharma Group plc
Via GlobeNewswire
News headline image
Mereo BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates
From Mereo BioPharma Group plc
Via GlobeNewswire
News headline image
MEREO LAWSUIT DEADLINE TODAY: Bragar Eagel & Squire, P.C. Urges Mereo BioPharma Stockholders with Large Losses to Contact the Firm Regarding Their Rights
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
MREO FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026
From Faruqi & Faruqi, LLP
Via Business Wire
News headline image
MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
MREO Deadline: Rosen Law Firm Urges Mereo BioPharma Group plc (NASDAQ: MREO) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
From Rosen Law Firm
Via Business Wire
News headline image
MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
MREO UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
MREO DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action – MREO
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines – MREO
From Pomerantz LLP
Via GlobeNewswire
News headline image
MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
INVESTOR ALERT: Berger Montague Advises Mereo BioPharma Group PLC (NASDAQ: MREO) Investors to Inquire About a Securities Fraud Class Action by April 6, 2026
From Berger Montague
Via GlobeNewswire
News headline image
MREO FINAL DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important April 6 Deadline in Securities Class Action – MREO
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
MREO Investor Alert - Mereo BioPharma Group plc Investors with Large Losses Should Contact Robbins LLP for Information About the Securities Fraud Class Action Lawsuit
From Robbins LLP
Via Business Wire
News headline image
MEREO LAWSUIT DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urges Mereo BioPharma Stockholders with Large Losses to Contact the Firm Before April 6th
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines – MREO
From Pomerantz LLP
Via GlobeNewswire
News headline image
MREO SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
Mereo BioPharma Reports Full Year 2025 Financial Results and Provides Corporate Highlights
From Mereo BioPharma Group plc
Via GlobeNewswire

Frequently Asked Questions

Is Mereo BioPharma Group plc - American Depositary Shares publicly traded?
Yes, Mereo BioPharma Group plc - American Depositary Shares is publicly traded.
What exchange does Mereo BioPharma Group plc - American Depositary Shares trade on?
Mereo BioPharma Group plc - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Mereo BioPharma Group plc - American Depositary Shares?
The ticker symbol for Mereo BioPharma Group plc - American Depositary Shares is MREO on the Nasdaq Stock Market
What is the current price of Mereo BioPharma Group plc - American Depositary Shares?
The current price of Mereo BioPharma Group plc - American Depositary Shares is 0.2761
When was Mereo BioPharma Group plc - American Depositary Shares last traded?
The last trade of Mereo BioPharma Group plc - American Depositary Shares was at 09/01/26 02:38 PM ET
What is the market capitalization of Mereo BioPharma Group plc - American Depositary Shares?
The market capitalization of Mereo BioPharma Group plc - American Depositary Shares is 161.49M
How many shares of Mereo BioPharma Group plc - American Depositary Shares are outstanding?
Mereo BioPharma Group plc - American Depositary Shares has 161M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.